US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

706.38

+20.603.00%

Number of Gainers:72

Number of Losers:76

Number of Flat:6

PE:- -

High:707.30

Open:685.68

Low:683.13

Close:685.75

Volume:177.72M

Turnover:5.89B

Market Cap:492.20B

Float Cap:373.73B

Loading ...

Is SentinelOne (S) Using New AWS AI Ties To Cement a Stickier Security Ecosystem?

Simply Wall St.

Riskified Shares Rise on Lifted Outlook

Analysts Have Conflicting Sentiments on These Utilities Companies: Oklo Inc (OKLO), Spire (SR) and Consolidated Edison (ED)

Century Therapeutics Q2 Net Loss Misses Estimates on Lease Termination Loss

Singapore's Audience Analytics H1 Profit Jumps on Higher Contracted Services Fulfilment

Acurx Says Japan, Mexico Patent Offices Grant New Patents for DNA Polymerase IIIC Inhibitor Antibiotics

Sprinklr Schedules Quarterly Results Release and Conference Call

Press Release: Sprinklr Announces Date of Second Quarter Financial Results

Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million

Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates

THOMSON REUTERS

Century Therapeutics Q2 Operating Expenses USD 36.527 Million

THOMSON REUTERS

Century Therapeutics Q2 Basic EPS USD -0.17

THOMSON REUTERS

Acumen Pharmaceuticals Posts Corporate Presentation on Sabirnetug Antibody Program for Early Alzheimer’s Disease

Lenz Climbs on Quarterly Revenue Beat

Nexxen Q2 FY26 Net Income Drops 58% to USD 3.64 Million; Revenue Rises 11% to USD 100.5 Million

LegalZoom (LZ) Receives a Hold from UBS

AbSci (ABSI) Gets a Buy from BTIG

Nexxen Names Chance Johnson President in Executive Reshuffle

Nexxen International Q2 Adj. EPS $0.23 Beats $0.20 Estimate, Sales $100.518M Beat $94.584M Estimate

Benzinga Earnings

Unicycive Therapeutics Q2 Net Loss Narrows on Warrant Liability Change

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK4539/news?page=47"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":706.3474,"timestamp":1787680519950,"preClose":685.7458,"halted":0,"volume":177704696,"delay":0,"changeRate":0.030043,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":20.601624,"latestTime":"08-25 13:55:20 EDT","open":685.6775,"high":707.3044,"low":683.1322,"amount":5893963592.15909,"amplitude":0.035249,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.436531,"peRate":156.391987,"turnoverRate":0.013785,"increases":72,"decrements":76,"flats":3,"marketCap":492200467705.625,"floatMarketCap":373728784623.375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":707.3044,"amplitude":0.035249,"preClose":685.7458,"low":683.1322,"pbRate":"5.436531","latestPrice":706.3775,"volume":177719313,"delay":0,"open":685.6775,"prevYearClose":881.5255,"prevWeekClose":700.9769,"prevMonthClose":673.0273,"prevQuarterClose":742.922,"fiveDayClose":655.4622,"twentyDayClose":704.4272,"sixtyDayClose":779.4826,"secType":"PLATE","market":"US","turnoverRate":0.013788,"peRate":156.391987,"marketCap":492264457412.125,"floatMarketCap":373782131374.375,"timestamp":1787680521215,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":72,"down":76,"flat":6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:47,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658085549","title":"Is SentinelOne (S) Using New AWS AI Ties To Cement a Stickier Security Ecosystem?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658085549","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658085549?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:26","pubTimestamp":1786537573,"startTime":"0","endTime":"0","summary":"In early August 2026, SentinelOne, ConnectWise, Amazon Web Services, and LevelBlue unveiled a series of AI-focused collaborations and platform enhancements, ranging from unified AI governance on Amazon Bedrock to governed, closed-loop response across the Singularity Platform and expanded Wayfinder Frontier AI Services.\nTogether, these moves underscore SentinelOne’s push to make AI-driven security both more automated and more governable, with managed service providers and large cloud...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8042000-choice1-main-header/1585186669041","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8042000-choice1-main-header/1585186669041"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nyse-s/sentinelone/news/is-sentinelone-s-using-new-aws-ai-ties-to-cement-a-stickier","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nyse-s/sentinelone/news/is-sentinelone-s-using-new-aws-ai-ties-to-cement-a-stickier","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARTY","LU2286300806.USD","BK4585","QTOC","BK4560","AIPO","VTHR","S","AGIX","BK4097","BK4561","BK4588","CHAT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658977851","title":"Riskified Shares Rise on Lifted Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2658977851","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658977851?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:22","pubTimestamp":1786537320,"startTime":"0","endTime":"0","summary":"Shares of Riskified were higher after the company lifted its outlook for a second time this year.The stock rose 13% to $5.94 in premarket trading Wednesday. Through the prior close, shares were up 10% this year.The e-commerce fraud prevention company said it now expects annual sales of $400 million to $410 million, up from its previous range of $376 million to $384 million.The higher guidance reflects a flow-through from outperformance in the second quarter, Riskified said.Revenue in the second quarter rose 22% to $98.7 million. Riskified narrowed its net loss to $9.1 million, or 7 cents a share, compared with a loss of $11.6 million, or 7 cents a share, the year before.The company is seeing increasing demand due to more complex fraud attacks, Chief Executive Eido Gal said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4539","RSKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972045","title":"Analysts Have Conflicting Sentiments on These Utilities Companies: Oklo Inc (OKLO), Spire (SR) and Consolidated Edison (ED)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972045?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:20","pubTimestamp":1786537208,"startTime":"0","endTime":"0","summary":"Companies in the Utilities sector have received a lot of coverage today as analysts weigh in on Oklo Inc (OKLO), Spire (SR) and Consolidated Edison...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-utilities-companies-oklo-inc-oklo-spire-sr-and-consolidated-edison-ed-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-utilities-companies-oklo-inc-oklo-spire-sr-and-consolidated-edison-ed-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4197","SR","LU0170899867.USD","BK4208","BK4585","LU2346227817.USD","ED","OKLL","OKLO","URAN","BK4081","FXU","URA","BK4588","BK4539","NLR","BK4606","OKLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658143972","title":"Century Therapeutics Q2 Net Loss Misses Estimates on Lease Termination Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658143972","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658143972?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:09","pubTimestamp":1786536564,"startTime":"0","endTime":"0","summary":"Century Therapeutics Q2 net loss misses estimates on lease termination lossOverviewU.S. cell therapy developer's Q2 net loss widened yr/yr, missing analyst expectationsQ2 operating income missed analy","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4490G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","PROK","SANA","NKTX","IPSC","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972155","title":"Singapore's Audience Analytics H1 Profit Jumps on Higher Contracted Services Fulfilment","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972155","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972155?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:07","pubTimestamp":1786536466,"startTime":"0","endTime":"0","summary":"Singapore's Audience Analytics H1 profit jumps on higher contracted services fulfilmentOverviewSingapore business media firm's H1 revenue rose 12.6% yr/yr on higher contracted service fulfilmentNet pr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4490FV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4009","BK4539","BK4023","NIQ","SMWB","1AZ.SI","BK6002","BK6505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972981","title":"Acurx Says Japan, Mexico Patent Offices Grant New Patents for DNA Polymerase IIIC Inhibitor Antibiotics","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972981","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972981?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:04","pubTimestamp":1786536277,"startTime":"0","endTime":"0","summary":"Acurx says Japan, Mexico patent offices grant new patents for DNA polymerase IIIC inhibitor antibioticsAcurx Pharmaceuticals won new patents in Japan, Mexico covering its DNA polymerase IIIC inhibitor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL3YqZJ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4539","BK4139","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658726719","title":"Sprinklr Schedules Quarterly Results Release and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2658726719","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658726719?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:03","pubTimestamp":1786536225,"startTime":"0","endTime":"0","summary":"Sprinklr schedules quarterly results release and conference callSprinklr to release fiscal Q2 results before the market opens on Sept. 2, 2026.Conference call set for 8:30 a.m. ET on Sept. 2, 2026, wi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLbgcYch:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CXM","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658729069","title":"Press Release: Sprinklr Announces Date of Second Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658729069","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658729069?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:03","pubTimestamp":1786536180,"startTime":"0","endTime":"0","summary":"NEW YORK--(BUSINESS WIRE)--August 12, 2026--Sprinklr (NYSE: CXM), the definitive, AI-native platform for Unified Customer Experience Management (Unified-CXM), today announced that the company's second","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CXM","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972509","title":"Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972509","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972509?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:01","pubTimestamp":1786536062,"startTime":"0","endTime":"0","summary":"BRIEF-Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 MillionAug 12 (Reuters) - Century Therapeutics Q2 basic EPS USD -0.17.Q2 operating expenses USD 36.527 millionQ2 operating income USD -36.527 million vs. IBES estimate USD -24.5 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXWB2XKL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4539","IPSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972551","title":"Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972551?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:00","pubTimestamp":1786536004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA4C572M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4539","IPSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972564","title":"Century Therapeutics Q2 Operating Expenses USD 36.527 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972564?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:00","pubTimestamp":1786536002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXWB2XKL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","IPSC","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658197258","title":"Century Therapeutics Q2 Basic EPS USD -0.17","url":"https://stock-news.laohu8.com/highlight/detail?id=2658197258","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658197258?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:00","pubTimestamp":1786536002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXWB2XKL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IPSC","BK4539","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974095","title":"Acumen Pharmaceuticals Posts Corporate Presentation on Sabirnetug Antibody Program for Early Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974095","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974095?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:50","pubTimestamp":1786535457,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals posts corporate presentation on sabirnetug antibody program for early Alzheimer’s diseaseAcumen outlined late-2026 topline expectations for its fully enrolled ALTITUDE-AD Phase ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL4nrmbt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABOS","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974419","title":"Lenz Climbs on Quarterly Revenue Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974419","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974419?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:41","pubTimestamp":1786534868,"startTime":"0","endTime":"0","summary":"BUZZ-Lenz climbs on quarterly revenue beat** Shares of eye drop maker Lenz TherapeuticsLENZ.Orise 7.7% to $5.61 premarket** Co'sQ2revenue of $5.5 million beats analysts' average expectation of $2.4 mi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4N4490UC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974430","title":"Nexxen Q2 FY26 Net Income Drops 58% to USD 3.64 Million; Revenue Rises 11% to USD 100.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974430","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974430?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:40","pubTimestamp":1786534807,"startTime":"0","endTime":"0","summary":"Nexxen Q2 FY26 net income drops 58% to USD 3.64 million; revenue rises 11% to USD 100.5 millionNexxen Q2 2026 revenue rose 11% to USD 100.5 million; programmatic revenue increased 12% to USD 95.2 mill","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLc5hYBv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4009","LU0314104364.USD","BCDF","IE00BKPKM429.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014005.SGD","LU2095319765.USD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","BK4539","NEXN","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4585","BK4588","IE00B3QW5Z07.USD","SG9999014039.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658742579","title":"LegalZoom (LZ) Receives a Hold from UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2658742579","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658742579?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:36","pubTimestamp":1786534603,"startTime":"0","endTime":"0","summary":"UBS analyst Stephen Ju maintained a Hold rating on LegalZoom today and set a price target of $7.00. According to TipRanks, Ju is a 5-star analyst w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/legalzoom-lz-receives-a-hold-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/legalzoom-lz-receives-a-hold-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4539","BK4123","LZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658197425","title":"AbSci (ABSI) Gets a Buy from BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2658197425","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658197425?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:36","pubTimestamp":1786534594,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Kambiz Yazdi from BTIG maintained a Buy rating on AbSci, with a price target of $13.00. The company’s shares closed...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/absci-absi-gets-a-buy-from-btig-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/absci-absi-gets-a-buy-from-btig-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABSI","BK4139","ARKG","BK4121","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658597460","title":"Nexxen Names Chance Johnson President in Executive Reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=2658597460","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658597460?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:33","pubTimestamp":1786534412,"startTime":"0","endTime":"0","summary":"Nexxen names Chance Johnson president in executive reshuffleNexxen named Chance Johnson president as it reorganizes commercial leadership to scale enterprise growth across its unified advertising plat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLbjc7f4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","BK4009","IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4112","BK4539","NEXN","NDAQ","LU2095319765.USD","LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4585","SG9999014013.SGD","LU2210149790.SGD","BK4588","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658694974","title":"Nexxen International Q2 Adj. EPS $0.23 Beats $0.20 Estimate, Sales $100.518M Beat $94.584M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658694974","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658694974?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:31","pubTimestamp":1786534290,"startTime":"0","endTime":"0","summary":"Nexxen International (NASDAQ:NEXN) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.20 by 15 percent. This is a 20.69 percent decrease over earnings of $0.29 per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61137586/nexxen-international-q2-adj-eps-0-23-beats-0-20-estimate-sales-100-518m-beat-94-584m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEXN","BK4539","BK4009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974615","title":"Unicycive Therapeutics Q2 Net Loss Narrows on Warrant Liability Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974615","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974615?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:31","pubTimestamp":1786534264,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics Q2 net loss narrows on warrant liability changeOverviewUS kidney disease biotech's Q2 net loss narrowed from prior yearNet loss decline attributed to change in fair value of war","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4490ED:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK","BK4139","SCYX","BK4539","UNCY","BK4007","ACHV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":54,"pageCount":47,"totalSize":1076,"code":"91000000","status":"200"}]}}